• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Key Achievements in Blockchain Industry: Updates and Prospects

user avatar

by Giorgi Kostiuk

a year ago


Recent changes in the blockchain world offer significant improvements in speed and efficiency, with promising projects like BlockDAG, Celestia, and Render.

BlockDAG: Growth and New Opportunities

BlockDAG is making significant strides with its partnership with HackerEarth, engaging more than 10,000 developers. The goal is to launch over 200 projects, focusing on solving blockchain scalability issues. Key technologies include Phantom and GhostDAG protocols, enhancing transaction speed and efficiency.

Celestia's Acceleration and Impact

Celestia's recent update reduced block times from 30 to 15 seconds, doubling data throughput. This makes Celestia appealing for developers seeking scalable solutions. Its native asset, TIA, is priced at $5.07, emphasizing its status in the blockchain space.

Render on Solana: New Horizons

Render shows significant growth by transitioning to the Solana network. This reduces transaction costs and increases efficiency, making Render ideal for demanding rendering needs. Analysts predict further price increases, reinforcing Render's position in decentralized GPU computing.

The steady growth and innovations from BlockDAG, Celestia, and Render solidify their positions in the blockchain industry. Partnerships and updates are opening new avenues for the development and adoption of Web3 technologies.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.